Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7323
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02 (Image 02)
Image-03 (Image 03)
This text appears to show data related to the effects of various drugs on the pharmacokinetics of venlafaxine. The information includes fold change values and 90% confidence intervals for parameters such as maximum concentration (Cmax) and area under the curve (AUC) when these drugs interact with venlafaxine. Different drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium are mentioned, along with their impact on venlafaxine. The text also references CYP2D6 EM's and CYP2DS PM's for specific drug interactions with venlafaxine.*
Image-04 (Image 04)
The text appears to be a list of interacting drugs and analytes including substances like ethanol, diazepam, alprazolam, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. It also mentions active moieties and fold change with 90% confidence interval in the context of drug interaction evaluation.*
Label Image (Lbl500907323)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.